This is a competitive renewal application for continuation of the Hypertension SCOR Grant 5P50 HL55001. The new proposal consists of four scientific projects and two supporting core units. Project I, a continuation of the ongoing clinical project, will expand our collection of hypertensive families, including subjects who have undergone extensive clinical evaluation and can be subgrouped into intermediate phenotypes, as well as families from genetically isolated populations from Greece, Israel and South Africa. Various subsets of our population will be submitted to different genetic analyses as appropriate, including linkage and association studies, genome-wide scan for genetic isolates, evaluation of single nucleotide polymorphisms in selected genes, testing of QTL by microsatellite markers and mapping of promising narrow regions by DNA sequencing Project II, also a continuation of the same project in the current SCOR, will identify and marrow down new and previously described QTL in hypertensive or salt-sensitive mice, targeting regions from which information can be applied to study of homologous human regions. Project II, also a mouse genome project, will further build on analysis of QTL mapping data from inbred mouse crosses of project II and will apply novel statistical methods for QTL mapping data from inbred mouse crosses of Project II and will apply novel statistical methods for the design and analysis of gene expression microarray experiments that may then be applied to analysis of human DNA samples. Project IV, a continuation of the same projects in the current SCOR, will study cellular and molecular mechanisms by which neurohormonal factors cause atherogenesis and cardiac injury both in vitro, using selected cell cultures, and in vivo, using genetically engineered animals. An injury both in vitro, using selected cell cultures, and in vivo, using genetically engineered animals. An Animal Core and an Administrative Core unit will facilitate and coordinate these projects. It is anticipated that crossing information from human and murine genetic studies will help identify genetic contributors to certain types of hypertension or its complications.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL055001-09
Application #
6705038
Study Section
Special Emphasis Panel (ZHL1-CSR-E (S1))
Program Officer
Lin, Michael
Project Start
1996-02-01
Project End
2006-01-31
Budget Start
2004-02-01
Budget End
2005-01-31
Support Year
9
Fiscal Year
2004
Total Cost
$1,975,093
Indirect Cost
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Duka, Arvi; Schwartz, Faina; Duka, Irena et al. (2006) A novel gene (Cmya3) induced in the heart by angiotensin II-dependent but not salt-dependent hypertension in mice. Am J Hypertens 19:275-81
Shenouda, Sherene M; Johns, Conrado; Kintsurashvili, Ekaterina et al. (2006) Long-term inhibition of the central alpha(2B)-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive rats. Am J Hypertens 19:1135-43
Cardoso de Carvalho, Fabio; Bregagnollo, Edson; Santos Silva, Vanessa et al. (2006) Frequency of coronary artery disease in patients with renal artery stenosis without clinical manifestations of coronary insufficiency. Am J Hypertens 19:1125-8
Cui, Jing; Melista, Efthymia; Chazaro, Irmarie et al. (2005) Sequence variation of bradykinin receptors B1 and B2 and association with hypertension. J Hypertens 23:55-62
Manolis, Athanasios J; Iraklianou, Stella; Pittaras, Andreas et al. (2005) Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy. Am J Hypertens 18:18-22
Ignjacev-Lazich, Ivana; Kintsurashvili, Ekaterina; Johns, Conrado et al. (2005) Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol Heart Circ Physiol 289:H1814-20
Russo, Christopher J; Melista, Efthymia; Cui, Jing et al. (2005) Association of NEDD4L ubiquitin ligase with essential hypertension. Hypertension 46:488-91
Schwartz, Faina; Duka, Arvi; Duka, Irena et al. (2004) Novel targets of ANG II regulation in mouse heart identified by serial analysis of gene expression. Am J Physiol Heart Circ Physiol 287:H1957-66
Elijovich, Fernando; Laffer, Cheryl L; Schiffrin, Ernesto L et al. (2004) Endothelin-aldosterone interaction and proteinuria in low-renin hypertension. J Hypertens 22:573-82
Schwartz, Faina; Duka, Arvi; Triantafyllidi, Elena et al. (2003) Serial analysis of gene expression in mouse kidney following angiotensin II administration. Physiol Genomics 16:90-8

Showing the most recent 10 out of 37 publications